Dr. Sudhir Diwan talks about his approach to pain medicine with the use of his office, surgery centers, and hospitals. He explains a new procedure he has started in his practice for sacral insufficiency in which he uses allogenic bone graft to fuse the SI joint. He also discusses his use of regenerative medicine, PRP, in his practice for both musculoskeletal and spinal pathologies and the reimbursement difficulties with these treatments.
Published on November 14, 2022
Dr. Sudhir Diwan talks about his approach to pain medicine with the use of his office, surgery centers, and hospitals. He explains a new procedure he has started in his practice for sacral insufficiency in which he uses allogenic bone graft to fuse the SI joint. He also discusses his use of regenerative medicine, PRP, in his practice for both musculoskeletal and spinal pathologies and the reimbursement difficulties with these treatments.
Dr. Sudhir Diwan talks about his approach to pain medicine with the use of his office, surgery centers, and hospitals. He explains a new procedure he has started in his practice for sacral insufficiency in which he uses allogenic bone graft to fuse the SI joint. He also discusses his use of regenerative medicine, PRP, in his practice for both musculoskeletal and spinal pathologies and the reimbursement difficulties with these treatments.
You must be logged in to post a review.
Dr. Sanford Silverman discusses the current opioid “epidemic” in this country. He has co-authored a book on this very topic, as he has experienced this opioid problem first hand as a pain management physician in Florida for twenty years. He also mentions that with ASIPP has a controlled substance management course, offered as a CME credits.
Dr. David Rosenblum discusses the webinars and podcasts he has created to help doctors do well on board exams. He explains how different medical backgrounds can be deficient in some aspects as it pertains to physiatry. One of many examples he gives is that anesthesiologist may require further education on radiology. He has created hundreds of questions from current syllabi in several medical specialties, topics that may not have been discussed during their fellowship.
Richard Rosenthal, MD, discusses allogenic cell therapy. The Food and Drug Administration (FDA) has not approved the injection of live cells in patients due to concerns about transmission or disease and uncontrolled cell growth. Instead, acellular methods such as injecting amniotic fluid or exosomes produced by mesenchymal stem cells can be used. These fluids come from donors and contain growth factors and matrix-building proteins that have regenerative effects.
Dr. Annu Navani discusses the use of regenerative medicine in her practice and the positive results these natural injection have on her patients. An explanation is given on the use of platelet-rich plasma (PRP) and bone marrow-derived mesenchymal stem cells, including how they are safely harvested from the patient’s body. She gives advice to those physicians who are interested in implementing regenerative medicine as a part of their practice. Dr. Navani has also published several articles that supports the effectiveness of this treatment.
Reviews
There are no reviews yet.